当前位置: 首页 > 期刊 > 《中国医药导报》 > 2019年第3期
编号:1357315
从汉方药的发展探讨中医药的传承与保护
http://www.100md.com 2019年3月18日 中国医药导报 2019年第3期
     余黄合 曾嵘 李鑫 王炜 蔡雄

    [摘要] 汉方药是在中医药理论传入日本本土化后所应用的药物,在其发展过程中,形成了独具特色的医疗体系。近些年,国家对中医药的重视与中医药的本身实力使其越来越国际化,在保护人类健康的道路上做出了巨大的贡献。因此我国对中医药的传承与保护的责任日益增大。本文将从汉方药的背景形势、监管与研发、专利保护等方面分析其迅速发展的原因,并提出对中医药进行严格质量监管、重视研发、加强专利保护等举措,以切实传承、保护并发展好这一重要资源。

    [关键词] 汉方药;中医药;中药材;传承;保护

    [中图分类号] R288? ? ? ? ? [文献标识码] A? ? ? ? ? [文章编号] 1673-7210(2019)01(c)-0132-04

    [Abstract] Kampo medicine is a medicine applied under the guidance of the localization of traditional Chinese medicine (TCM) to Japan. In the process of its development, it has formed a unique medical system. In recent years, national emphasis on TCM and TCM strength have made it more and more internationalized, and have got great contributions to the protection of human health. Therefore, the responsibility for the inheritance and protection of TCM is increasing. This article analyzes the cause of rapid development, supervision and research, patent protection and other factors from the background of kampo medicine. In order to inherit, protect and develop this important cultural resource, we put forward some measures to strictly supervise the quality of Chinese medicine ......

您现在查看是摘要页,全文长 12395 字符